Relapsed and refractory peripheral T-cell lymphoma
Showing 9951 - 9975 of >10,000
Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)
Recruiting
- Relapsing Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 28, 2022
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Panitumumab
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jun 4, 2023
Arthroplasty, Replacement, Hip Trial in Toronto (Low Concentration Local Anesthetic Fascia Iliaca Compartment Block, High
Recruiting
- Arthroplasty, Replacement, Hip
- Low Concentration Local Anesthetic Fascia Iliaca Compartment Block
- High Concentration Local Anesthetic Fascia Iliaca Compartment Block
-
Toronto, Ontario, CanadaMount Sinai Hospital
Oct 26, 2023
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- (no location specified)
Aug 4, 2023
Lung Cancer Trial in Toulouse (Blood samples will be collected at two times before the treatment initiation:)
Not yet recruiting
- Lung Cancer
- Blood samples will be collected at two times before the treatment initiation:
-
Toulouse, France
- +1 more
Aug 3, 2023
Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment
Completed
- Mild Cognitive Impairment
- Idebenone
- Naohuan Dan and Idebenone
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 5
Jun 29, 2023
Vascular Access Trial (Buzzy device plus EMLA cream, Only EMLA cream)
Not yet recruiting
- Vascular Access
- Buzzy device plus EMLA cream
- Only EMLA cream
- (no location specified)
Mar 4, 2022
Peripheral Perfusion Index To Detect Changes of Hemodynamics in
Recruiting
- Pacemaker Dependence
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jul 9, 2021
Exercise Capacity, Pulmonary Function and Physical Activity
Completed
- Pneumonectomy; Status
-
Ankara, Çankaya, TurkeyGazi University Faculty of Health Sciences Department of Physiot
Aug 12, 2022
Postural Tachycardia Syndrome, Orthostatic Intolerance Trial in Nashville (Carbidopa, Placebo)
Completed
- Postural Tachycardia Syndrome
- Orthostatic Intolerance
- Carbidopa
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 14, 2022
Food and Cooking Skills, and Eating Behaviors in People With
Completed
- Obesity
- Overweight
- Food and cooking skills
-
Balıkesir, TurkeyYeni mh. Bandirma Onyedi Eylul University Faculty of Health Scie
Oct 12, 2022
PENG Block Trial in Aydin (PENG block)
Recruiting
- PENG Block
- PENG block
-
Aydın, TurkeyAdnan Menderes University Faculty of Medicine
Aug 9, 2023
IL- 6 Gene Single Nucleotide Polymorphism asIndicator of
Completed
- Covid19
- interleuken 6 level measurment
- Interleukin-6 Gene-174C detection
-
Tanta, El Gharbyia, EgyptBsant Safwat Kasem
May 1, 2022
Elderly Population in SheMountain
Not yet recruiting
- Alzheimer Disease
- +4 more
-
Shanghai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Dec 28, 2022
Metastatic Colorectal Cancer, Metastatic Colon Cancer Trial in Worldwide (Fruquintinib, Placebo)
Active, not recruiting
- Metastatic Colorectal Cancer
- Metastatic Colon Cancer
- Fruquintinib
- Placebo
-
Phoenix, Arizona
- +152 more
Mar 10, 2022
Breast Self-Examination Trial in Bayburt (Training and application in breast modeling, Control)
Completed
- Breast Self-Examination
- Training and application in breast modeling
- Control
-
Bayburt, TurkeyBayburt University
Jul 21, 2023
Tumors Trial in Miami, Tampa, Houston (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)
Completed
- Neoplasms
- letetresgene autoleucel (GSK3377794)
- +2 more
-
Miami, Florida
- +2 more
Aug 10, 2021
Cancer of Unknown Primary Site Trial in Heidelberg (Nivolumab/Ipilimumab)
Recruiting
- Cancer of Unknown Primary Site
- Nivolumab/Ipilimumab
-
Heidelberg, GermanyUniversity of Heidelberg
Apr 14, 2020
Colon Cancer Trial in Slagelse (Metformin Hydrochloride, Placebo oral capsule)
Completed
- Colon Cancer
- Metformin Hydrochloride
- Placebo oral capsule
-
Slagelse, DenmarkDepartment of Surgery, Slagelse Hospital
Mar 2, 2022
OSTEOMICS: Identifying Regulators of Bone Homeostasis
Active, not recruiting
- Osteoporosis
- +4 more
- Relevant orthopaedic surgery
-
London, Greater London, United KingdomHarley Street Specialist Hospital
Feb 8, 2023
Covid19 Virus Infection Trial in Rockville (Inflammation (I), Inflammation (II), Inflammation (III))
Recruiting
- Covid19 Virus Infection
- Inflammation (I)
- +3 more
-
Rockville, MarylandAll Natural Medicine Clinic, LLC
Oct 31, 2021